Results Press Release
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated July 30, 2014 titled "Zydus Cadila Q1 Net Profit up by 23%".30-07-2014
30-07-2014
Announces Q1 Results
Cadila Healthcare Ltd has announced the following results for the quarter ended June 30, 2014:The Unaudited Standalone results for the Quarter ended June 30, 2014The Company has posted a net profit of Rs. 1972.90 million for the quarter ended June 30, 2014 as compared to Rs. 3402.20 million for the quarter ended June 30, 2013. Total Income has decreased from Rs. 11476.40 million for the quarter ended June 30, 2013 to Rs. 11291.30 million for the quarter ended June 30, 2014....30-07-2014
Q1 results on July 30, 2014
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 30, 2014, inter alia, to consider & approve the unaudited financial results for the quarter ended on June 30, 2014 (Q1).Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992, the Trading Window will remain close from July 21, 2014...09-07-2014
Shareholding Pattern For June 30, 2014
Cadila Healthcare Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.07-07-2014
AGM on July 30, 2014
Cadila Healthcare Ltd has informed BSE that the 19th Annual General Meeting (AGM) of the Company will be held on July 30, 2014.02-07-2014
Cut-off Date for E-Voting
Cadila Healthcare Ltd has informed BSE that:"The Company has informed on May 31, 2014 the closure of Register of Members from July 21, 2014 to July 30, 2014 [both days inclusive] for determining the names of members eligible for dividend on the equity shares and for Annual General meeting for the financial year ended on March 31, 2014....30-06-2014
Press Release
Cadila Healthcare Ltd has submitted to BSE a copy of press release dated June 11, 2014 regarding finalization of previously announced agreement with Warner Chilcoot Company LLC, a subsidiary of Actavis plc by the Company and Zydus Pharmaceuticals (USA), a subsidiary of the Company, to settle all outstanding patent litigation related to Asacol HD (mesalamine) delayed- release tablets, to be released in the News Papers.11-06-2014